BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36704593)

  • 21. Use of high-dose denosumab in the management of immobilization-related hypercalcemia in an end-stage renal disease patient on hemodialysis: A case report and review of the literature.
    Zaitoun MF; Al-Alsheikh KA; Elnazer W
    Clin Nephrol; 2021 Dec; 96(6):353-356. PubMed ID: 34605398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The incidence and prognostic significance of humoral hypercalcemia in renal cell carcinoma.
    Fahn HJ; Lee YH; Chen MT; Huang JK; Chen KK; Chang LS
    J Urol; 1991 Feb; 145(2):248-50. PubMed ID: 1988711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
    Onuma E; Azuma Y; Saito H; Tsunenari T; Watanabe T; Hirabayashi M; Sato K; Yamada-Okabe H; Ogata E
    Clin Cancer Res; 2005 Jun; 11(11):4198-203. PubMed ID: 15930357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interpretation of hypercalcemia in a patient with end-stage renal disease.
    Nora NA; Singer I
    Arch Intern Med; 1992 Jun; 152(6):1321-2. PubMed ID: 1599363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Sarcoidosis and hypercalcemia in a patient undergoing hemodialysis].
    Kuwae N; Oshiro Y; Nakazato S
    Nihon Jinzo Gakkai Shi; 2003; 45(2):98-103. PubMed ID: 12703405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of severe hypercalcemia with peritoneal dialysis in an infant with end-stage renal disease.
    Querfeld U; Salusky IB; Fine RN
    Pediatr Nephrol; 1988 Jul; 2(3):323-5. PubMed ID: 3153036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypercalcemic hypertension in hemodialysis.
    Sica DA; Harford AM; Zawada ET
    Clin Nephrol; 1984 Aug; 22(2):102-4. PubMed ID: 6548177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. First Japanese patient treated with parathyroid hormone peptide immunization for refractory hypercalcemia caused by metastatic parathyroid carcinoma.
    Horie I; Ando T; Inokuchi N; Mihara Y; Miura S; Imaizumi M; Usa T; Kinoshita N; Sekine I; Kamihara S; Eguchi K
    Endocr J; 2010; 57(4):287-92. PubMed ID: 20051648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypercalcemia in squamous cell carcinoma of the renal pelvis? Parathyroid or paraendocrine in origin.
    Schaefer CJ; Geelhoed GW
    Am Surg; 1986 Oct; 52(10):560-3. PubMed ID: 2876667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Shoulder pad sign and asymptomatic hypercalcemia in a patient with end-stage kidney disease.
    Izawa S; Akimoto T; Ikeuchi H; Kusano E; Nagata D
    Clin Med Insights Case Rep; 2015; 8():27-31. PubMed ID: 25861231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Denosumab treatment for refractory hypercalcemia in a hemodialysis patient with tertiary hyperparathyroidism.
    Zhang P; Yu Y; Gao Y; Yuan G; Zhang J; Wang W
    Hemodial Int; 2023 Apr; 27(2):E23-E28. PubMed ID: 36719850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The emerging role of denosumab in the long-term management of parathyroid carcinoma-related refractory hypercalcemia.
    Fountas A; Andrikoula M; Giotaki Z; Limniati C; Tsakiridou E; Tigas S; Tsatsoulis A
    Endocr Pract; 2015 May; 21(5):468-73. PubMed ID: 25667369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypocalcemia in end-stage renal disease: a consequence of spontaneous parathyroid gland infarction.
    Hammes M; DeMory A; Sprague SM
    Am J Kidney Dis; 1994 Sep; 24(3):519-22. PubMed ID: 8079980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Refractory hypercalcemia in patient with lung cancer].
    Grzywacz A; Dziuk M; Niemczyk S
    Pol Merkur Lekarski; 2014 Apr; 36(214):261-4. PubMed ID: 24868900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal sarcoidosis with normal serum vitamin D and refractory hypercalcemia.
    Unsal A; Basturk T; Koc Y; Sakacı T; Ahbap E; Ozagarı A; Arar AS; Akgül C; Sevınc M
    Int Urol Nephrol; 2013 Dec; 45(6):1779-83. PubMed ID: 22826146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Textiloma-Induced 1,25-Dihydroxyvitamin D-Mediated Hypercalcemia: A Case Report and Literature Study.
    de Bellefroid J; Vandecasteele S; Van Cauwenberge S; Bouillon R; Van den Bruel A
    J Endocr Soc; 2019 Nov; 3(11):2158-2164. PubMed ID: 31687642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of denosumab for renal cell carcinoma-associated malignant hypercalcemia: a case report and review of the literature.
    Freeman A; El-Amm J; Aragon-Ching JB
    Clin Genitourin Cancer; 2013 Dec; 11(4):e24-6. PubMed ID: 24007982
    [No Abstract]   [Full Text] [Related]  

  • 38. Hypercalcemia during the polyuric stage of acute renal failure.
    Wysenbeek A; Goldsmidt Z; Nemesh L; Rosenfeld JB
    Isr J Med Sci; 1976 Nov; 12(11):1316-9. PubMed ID: 1017934
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Electron beam computed tomography of the heart before kidney transplantation. Severe coronary disease in a 21-year old woman with nephrocalcinosis due to infantile hypercalcemia syndrome].
    Hunold P; Wieneke H; Schmermund A; Eggebrecht H; Bonzel KE; Grönemeyer D; Erbel R
    Med Klin (Munich); 2001 Mar; 96(3):161-5. PubMed ID: 11315400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Severe hyperparathyroidism with hypercalcemia associated with chronic renal failure at pre-dialysis stage.
    Takasaki I; Shionoiri H; Yabana M; Takagi N; Kamijo S; Nakatani Y; Umemura S
    Endocr J; 1999 Feb; 46(1):167-71. PubMed ID: 10426582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.